N-(Hydroxymethyl)nicotinamide

Published date: 2020-03-27 16:47:18
N-(Hydroxymethyl)nicotinamide Structure
Share to Facebook Share to Twitter Share to Linkedin
Name N-(Hydroxymethyl)nicotinamide CAS# 3569-99-1
Price ￥Inquiry/1kg Purity 98.8%
Stocking
Period		 Inquiry Stock Inquiry
 Detail Product Information
Chemical & Physical Properties:
CAS Number: 3569-99-1
Name: N-(Hydroxymethyl)nicotinamide
Molecular Formula: C7H8N2O2
Molecular Weight: 152.151
Density: 1.3±0.1 g/cm3
Boiling Point: 427.7±25.0 °C at 760 mmHg
Melting Point: 152-154 °C(lit.)
Flash Point: 212.5±23.2 °C
Supplier/Manufacture

Shaanxi Xiyue Pharmaceutical Co., Ltd.

Chemsrc Level: Unverified
Tel: 88230456
Address: Floor 7, Qihang Block A, Houweizhai, Weiyang district, Xi'an city, Shaanxi province, China.
Area: China
Contact: Lisa Kang
Contact Phone #: +86-15129023597
Email: market@xiyuezy.com
Website: http://www.xiyuezy.com
Foreign Trade % of Sales: 10%
Major partners:
Shaanxi Xiyue Pharmaceutical Co., Ltd. (hereinafter referred to as “Xiyue Pharma”) is a professional manufacturing enterprise mainly engaged in R&D and production of APIs. Xiyue Pharma was founded in 1968. Its predecessor was the Northwest Second Synthetic Pharmaceutical Factory, which was affiliated to the Ministry of Chemical Industry and was the largest API production base in Western China. In 2008, Xiyue Pharma was wholly-owned acquired by Shaanxi Haichenyunhe Pharmaceutical Technology Co., Ltd. and was transformed into an efficient, and professional private high-tech enterprise. The company is headquartered in Xi'an, the start of the world-known Silk Road, and the ancient capital of China. It now has two manufacturing factories, which are located in Huayin Biomedical Industrial Park and Baoji Fufeng Science and Technology Industrial Park, covering a total area of ​​more than 200,000 square meters.
Xiyue Pharma currently has 113 approval numbers, including 23 API approvals and 90 preparation approvals. The products cover a wide range of cardiovascular and cerebrovascular, nervous system, antipyretic and analgesic, digestive fields and so on. The company has established and perfected the quality management system in strict accordance with the new national GMP standards. It has more than 10 production lines of APIs, tablets, capsules and granules, etc. Its production scale, technical level, brand influence and economic benefits rank among the top in the domestic industry. The company's products are mainly sold in domestic and are widely used in overseas markets. The domestic market share of products like Nifedipine and Aceglutamide, etc. is leading, and Diclofenac Sodium has been sold to countries such as Argentina and Pakistan. The company also undertakes international API processing business and has established strategic partnerships with many famous domestic and foreign companies, such as the Shanghai Pharmaceuticals Holding Co. Ltd. (“SPH” Group), China National Pharmaceutical Group Co., Ltd. (Sinopharm) and Buchang Pharmaceuticals (Buchang Pharma).
Xiyue Pharma has more than 300 employees, including more than 100 professional and technical personnels, and more than 30 senior and intermediate researchers. The company attaches great importance to the development of new products, invests a large amount of funds each year for research and development, and has established a pharmaceutical research institute by a number of doctors and masters. It has maintained a long-term close cooperation with many domestic research institutions in production and research, to ensure the products’ technology innovation and new products’ launch, and to meet the diverse needs of customers at home and abroad.
Xiyue Pharma also pays great attention to the environmental protection and has passed various inspections of the national environmental assessment of the pharmaceutical industry. The production strictly follows the EHS policy, strengthens the prevention principle of the whole process, and eliminates any environmental pollution and social hazard accidents, to ensure a safe, efficient and consistent supply of products. The Company adhering to the "people-oriented, care for health" corporate philosophy, is committed to making Xiyue Pharma an internationally renowned, domestic leading API pharmaceutical manufacturing enterprise.
Top Suppliers:

Get all suppliers by the below link:

N-(Hydroxymethyl)nicotinamide suppliers

Price: ￥514.8/25g
Price from the other suppliers:
2024-07-15 N-(Hydroxymethyl)nicotinamide
Price: Inquiry
2019-03-05 N-(Hydroxymethyl)nicotinamide
Price: ￥618.0
2020-12-18 N-(Hydroxymethyl)nicotinamide
Price: $Inquiry
2021-07-26 N-(Hydroxymethyl)nicotinamide
Price: $Inquiry
2022-09-23 N-(Hydroxymethyl)nicotinamide
Price: ￥389.0

Get all price from the following link:

N-(Hydroxymethyl)nicotinamideprice

Related product price:
N-(Hydroxymethyl)nicotinamide price is ￥Inquiry/1kg. Find complete details about N-(Hydroxymethyl)nicotinamide product information includes price/quote, purity, stocking period etc. from Shaanxi Xiyue Pharmaceutical Co., Ltd.>>Mobile(AMP) version: N-(Hydroxymethyl)nicotinamide Price from Supplier Brand Shaanxi Xiyue Pharmaceutical Co., Ltd.

Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer

Copyright © 2024 ChemSrc All Rights Reserved